 | • レポートコード：QYR2104Z1345 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、シスプラチンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、注射）、用途別市場規模（精巣がん、骨肉腫、乳がん）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・シスプラチンの市場動向 ・企業の競争状況、市場シェア ・シスプラチンの種類別市場規模（錠剤、注射） ・シスプラチンの用途別市場規模（精巣がん、骨肉腫、乳がん） ・シスプラチンの北米市場規模2016-2027（アメリカ、カナダ） ・シスプラチンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・シスプラチンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・シスプラチンの中南米市場規模2016-2027（メキシコ、ブラジル） ・シスプラチンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Eli Lilly and Company、Hospira、Pfizer、Bedford Pharmaceuticals、Alvogen、Athenex Pharmaceutical、Gland Pharma (Fosun Pharma)、West-Ward Pharmaceuticals、WG Critical Care、David Bull Laboratories、Omega Laboratories、Fresenius Kabi、TEVA、Mylan Pharmaceuticals、Yunnan Plant Pharmaceutical、Yunnan Biological Valley Pharmaceutical、Dezhou de Pharmaceutical、Jiangsu Haosen Pharmaceutical Group、Qilu Pharmaceutical） ・結論 |
Cisplatin is one of the most commonly used drugs in current combined chemotherapy. Its chemical name is cis-dichlorodiaminoplatin, which is an inorganic metal complex. After chlorine dissociation, it cross-connects with the DNA of cancer cells, thus damaging the function of DNA.It may form intracyclic Chemicalbook or cross-linking with DNA, or it may form cross-linking with DNA and proteins, and inhibit cell mitosis. It is a non-specific drug in cell cycle, which can inhibit lymphocyte transformation in addition to anticancer, has immunosuppressive effect, and can be used as metal complexes for anticancer drugs.
Market Analysis and Insights: Global Cisplatin Market
The global Cisplatin market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cisplatin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cisplatin market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cisplatin market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cisplatin market.
Global Cisplatin Scope and Market Size
Cisplatin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cisplatin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Tablets
Injection
Segment by Application
Testicular Cancer
Osteosarcoma
Breast Cancer
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Eli Lilly and Company
Hospira
Pfizer
Bedford Pharmaceuticals
Alvogen
Athenex Pharmaceutical
Gland Pharma (Fosun Pharma)
West-Ward Pharmaceuticals
WG Critical Care
David Bull Laboratories
Omega Laboratories
Fresenius Kabi
TEVA
Mylan Pharmaceuticals
Yunnan Plant Pharmaceutical
Yunnan Biological Valley Pharmaceutical
Dezhou de Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cisplatin Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tablets
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Cisplatin Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Testicular Cancer
1.3.3 Osteosarcoma
1.3.4 Breast Cancer
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cisplatin Market Perspective (2016-2027)
2.2 Cisplatin Growth Trends by Regions
2.2.1 Cisplatin Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cisplatin Historic Market Share by Regions (2016-2021)
2.2.3 Cisplatin Forecasted Market Size by Regions (2022-2027)
2.3 Cisplatin Industry Dynamic
2.3.1 Cisplatin Market Trends
2.3.2 Cisplatin Market Drivers
2.3.3 Cisplatin Market Challenges
2.3.4 Cisplatin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cisplatin Players by Revenue
3.1.1 Global Top Cisplatin Players by Revenue (2016-2021)
3.1.2 Global Cisplatin Revenue Market Share by Players (2016-2021)
3.2 Global Cisplatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cisplatin Revenue
3.4 Global Cisplatin Market Concentration Ratio
3.4.1 Global Cisplatin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cisplatin Revenue in 2020
3.5 Cisplatin Key Players Head office and Area Served
3.6 Key Players Cisplatin Product Solution and Service
3.7 Date of Enter into Cisplatin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cisplatin Breakdown Data by Type
4.1 Global Cisplatin Historic Market Size by Type (2016-2021)
4.2 Global Cisplatin Forecasted Market Size by Type (2022-2027)
5 Cisplatin Breakdown Data by Application
5.1 Global Cisplatin Historic Market Size by Application (2016-2021)
5.2 Global Cisplatin Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cisplatin Market Size (2016-2027)
6.2 North America Cisplatin Market Size by Type
6.2.1 North America Cisplatin Market Size by Type (2016-2021)
6.2.2 North America Cisplatin Market Size by Type (2022-2027)
6.2.3 North America Cisplatin Market Size by Type (2016-2027)
6.3 North America Cisplatin Market Size by Application
6.3.1 North America Cisplatin Market Size by Application (2016-2021)
6.3.2 North America Cisplatin Market Size by Application (2022-2027)
6.3.3 North America Cisplatin Market Size by Application (2016-2027)
6.4 North America Cisplatin Market Size by Country
6.4.1 North America Cisplatin Market Size by Country (2016-2021)
6.4.2 North America Cisplatin Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cisplatin Market Size (2016-2027)
7.2 Europe Cisplatin Market Size by Type
7.2.1 Europe Cisplatin Market Size by Type (2016-2021)
7.2.2 Europe Cisplatin Market Size by Type (2022-2027)
7.2.3 Europe Cisplatin Market Size by Type (2016-2027)
7.3 Europe Cisplatin Market Size by Application
7.3.1 Europe Cisplatin Market Size by Application (2016-2021)
7.3.2 Europe Cisplatin Market Size by Application (2022-2027)
7.3.3 Europe Cisplatin Market Size by Application (2016-2027)
7.4 Europe Cisplatin Market Size by Country
7.4.1 Europe Cisplatin Market Size by Country (2016-2021)
7.4.2 Europe Cisplatin Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cisplatin Market Size (2016-2027)
8.2 Asia-Pacific Cisplatin Market Size by Type
8.2.1 Asia-Pacific Cisplatin Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cisplatin Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cisplatin Market Size by Type (2016-2027)
8.3 Asia-Pacific Cisplatin Market Size by Application
8.3.1 Asia-Pacific Cisplatin Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cisplatin Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cisplatin Market Size by Application (2016-2027)
8.4 Asia-Pacific Cisplatin Market Size by Region
8.4.1 Asia-Pacific Cisplatin Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cisplatin Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cisplatin Market Size (2016-2027)
9.2 Latin America Cisplatin Market Size by Type
9.2.1 Latin America Cisplatin Market Size by Type (2016-2021)
9.2.2 Latin America Cisplatin Market Size by Type (2022-2027)
9.2.3 Latin America Cisplatin Market Size by Type (2016-2027)
9.3 Latin America Cisplatin Market Size by Application
9.3.1 Latin America Cisplatin Market Size by Application (2016-2021)
9.3.2 Latin America Cisplatin Market Size by Application (2022-2027)
9.3.3 Latin America Cisplatin Market Size by Application (2016-2027)
9.4 Latin America Cisplatin Market Size by Country
9.4.1 Latin America Cisplatin Market Size by Country (2016-2021)
9.4.2 Latin America Cisplatin Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cisplatin Market Size (2016-2027)
10.2 Middle East & Africa Cisplatin Market Size by Type
10.2.1 Middle East & Africa Cisplatin Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cisplatin Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cisplatin Market Size by Type (2016-2027)
10.3 Middle East & Africa Cisplatin Market Size by Application
10.3.1 Middle East & Africa Cisplatin Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cisplatin Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cisplatin Market Size by Application (2016-2027)
10.4 Middle East & Africa Cisplatin Market Size by Country
10.4.1 Middle East & Africa Cisplatin Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cisplatin Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Details
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Cisplatin Introduction
11.1.4 Eli Lilly and Company Revenue in Cisplatin Business (2016-2021)
11.1.5 Eli Lilly and Company Recent Development
11.2 Hospira
11.2.1 Hospira Company Details
11.2.2 Hospira Business Overview
11.2.3 Hospira Cisplatin Introduction
11.2.4 Hospira Revenue in Cisplatin Business (2016-2021)
11.2.5 Hospira Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Cisplatin Introduction
11.3.4 Pfizer Revenue in Cisplatin Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Bedford Pharmaceuticals
11.4.1 Bedford Pharmaceuticals Company Details
11.4.2 Bedford Pharmaceuticals Business Overview
11.4.3 Bedford Pharmaceuticals Cisplatin Introduction
11.4.4 Bedford Pharmaceuticals Revenue in Cisplatin Business (2016-2021)
11.4.5 Bedford Pharmaceuticals Recent Development
11.5 Alvogen
11.5.1 Alvogen Company Details
11.5.2 Alvogen Business Overview
11.5.3 Alvogen Cisplatin Introduction
11.5.4 Alvogen Revenue in Cisplatin Business (2016-2021)
11.5.5 Alvogen Recent Development
11.6 Athenex Pharmaceutical
11.6.1 Athenex Pharmaceutical Company Details
11.6.2 Athenex Pharmaceutical Business Overview
11.6.3 Athenex Pharmaceutical Cisplatin Introduction
11.6.4 Athenex Pharmaceutical Revenue in Cisplatin Business (2016-2021)
11.6.5 Athenex Pharmaceutical Recent Development
11.7 Gland Pharma (Fosun Pharma)
11.7.1 Gland Pharma (Fosun Pharma) Company Details
11.7.2 Gland Pharma (Fosun Pharma) Business Overview
11.7.3 Gland Pharma (Fosun Pharma) Cisplatin Introduction
11.7.4 Gland Pharma (Fosun Pharma) Revenue in Cisplatin Business (2016-2021)
11.7.5 Gland Pharma (Fosun Pharma) Recent Development
11.8 West-Ward Pharmaceuticals
11.8.1 West-Ward Pharmaceuticals Company Details
11.8.2 West-Ward Pharmaceuticals Business Overview
11.8.3 West-Ward Pharmaceuticals Cisplatin Introduction
11.8.4 West-Ward Pharmaceuticals Revenue in Cisplatin Business (2016-2021)
11.8.5 West-Ward Pharmaceuticals Recent Development
11.9 WG Critical Care
11.9.1 WG Critical Care Company Details
11.9.2 WG Critical Care Business Overview
11.9.3 WG Critical Care Cisplatin Introduction
11.9.4 WG Critical Care Revenue in Cisplatin Business (2016-2021)
11.9.5 WG Critical Care Recent Development
11.10 David Bull Laboratories
11.10.1 David Bull Laboratories Company Details
11.10.2 David Bull Laboratories Business Overview
11.10.3 David Bull Laboratories Cisplatin Introduction
11.10.4 David Bull Laboratories Revenue in Cisplatin Business (2016-2021)
11.10.5 David Bull Laboratories Recent Development
11.11 Omega Laboratories
11.11.1 Omega Laboratories Company Details
11.11.2 Omega Laboratories Business Overview
11.11.3 Omega Laboratories Cisplatin Introduction
11.11.4 Omega Laboratories Revenue in Cisplatin Business (2016-2021)
11.11.5 Omega Laboratories Recent Development
11.12 Fresenius Kabi
11.12.1 Fresenius Kabi Company Details
11.12.2 Fresenius Kabi Business Overview
11.12.3 Fresenius Kabi Cisplatin Introduction
11.12.4 Fresenius Kabi Revenue in Cisplatin Business (2016-2021)
11.12.5 Fresenius Kabi Recent Development
11.13 TEVA
11.13.1 TEVA Company Details
11.13.2 TEVA Business Overview
11.13.3 TEVA Cisplatin Introduction
11.13.4 TEVA Revenue in Cisplatin Business (2016-2021)
11.13.5 TEVA Recent Development
11.14 Mylan Pharmaceuticals
11.14.1 Mylan Pharmaceuticals Company Details
11.14.2 Mylan Pharmaceuticals Business Overview
11.14.3 Mylan Pharmaceuticals Cisplatin Introduction
11.14.4 Mylan Pharmaceuticals Revenue in Cisplatin Business (2016-2021)
11.14.5 Mylan Pharmaceuticals Recent Development
11.15 Yunnan Plant Pharmaceutical
11.15.1 Yunnan Plant Pharmaceutical Company Details
11.15.2 Yunnan Plant Pharmaceutical Business Overview
11.15.3 Yunnan Plant Pharmaceutical Cisplatin Introduction
11.15.4 Yunnan Plant Pharmaceutical Revenue in Cisplatin Business (2016-2021)
11.15.5 Yunnan Plant Pharmaceutical Recent Development
11.16 Yunnan Biological Valley Pharmaceutical
11.16.1 Yunnan Biological Valley Pharmaceutical Company Details
11.16.2 Yunnan Biological Valley Pharmaceutical Business Overview
11.16.3 Yunnan Biological Valley Pharmaceutical Cisplatin Introduction
11.16.4 Yunnan Biological Valley Pharmaceutical Revenue in Cisplatin Business (2016-2021)
11.16.5 Yunnan Biological Valley Pharmaceutical Recent Development
11.17 Dezhou de Pharmaceutical
11.17.1 Dezhou de Pharmaceutical Company Details
11.17.2 Dezhou de Pharmaceutical Business Overview
11.17.3 Dezhou de Pharmaceutical Cisplatin Introduction
11.17.4 Dezhou de Pharmaceutical Revenue in Cisplatin Business (2016-2021)
11.17.5 Dezhou de Pharmaceutical Recent Development
11.18 Jiangsu Haosen Pharmaceutical Group
11.18.1 Jiangsu Haosen Pharmaceutical Group Company Details
11.18.2 Jiangsu Haosen Pharmaceutical Group Business Overview
11.18.3 Jiangsu Haosen Pharmaceutical Group Cisplatin Introduction
11.18.4 Jiangsu Haosen Pharmaceutical Group Revenue in Cisplatin Business (2016-2021)
11.18.5 Jiangsu Haosen Pharmaceutical Group Recent Development
11.18 Qilu Pharmaceutical
.1 Qilu Pharmaceutical Company Details
.2 Qilu Pharmaceutical Business Overview
.3 Qilu Pharmaceutical Cisplatin Introduction
.4 Qilu Pharmaceutical Revenue in Cisplatin Business (2016-2021)
.5 Qilu Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cisplatin Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tablets
Table 3. Key Players of Injection
Table 4. Global Cisplatin Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Cisplatin Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cisplatin Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Cisplatin Market Share by Regions (2016-2021)
Table 8. Global Cisplatin Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Cisplatin Market Share by Regions (2022-2027)
Table 10. Cisplatin Market Trends
Table 11. Cisplatin Market Drivers
Table 12. Cisplatin Market Challenges
Table 13. Cisplatin Market Restraints
Table 14. Global Cisplatin Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Cisplatin Market Share by Players (2016-2021)
Table 16. Global Top Cisplatin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cisplatin as of 2020)
Table 17. Ranking of Global Top Cisplatin Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Cisplatin Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cisplatin Product Solution and Service
Table 21. Date of Enter into Cisplatin Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cisplatin Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Cisplatin Revenue Market Share by Type (2016-2021)
Table 25. Global Cisplatin Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Cisplatin Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Cisplatin Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Cisplatin Revenue Market Share by Application (2016-2021)
Table 29. Global Cisplatin Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Cisplatin Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Cisplatin Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Cisplatin Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Cisplatin Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Cisplatin Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Cisplatin Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Cisplatin Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Cisplatin Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Cisplatin Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Cisplatin Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Cisplatin Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Cisplatin Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Cisplatin Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Cisplatin Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Cisplatin Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cisplatin Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cisplatin Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cisplatin Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Cisplatin Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Cisplatin Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Cisplatin Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Cisplatin Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Cisplatin Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Cisplatin Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Cisplatin Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Cisplatin Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Cisplatin Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cisplatin Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cisplatin Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cisplatin Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Cisplatin Market Size by Country (2022-2027) & (US$ Million)
Table 61. Eli Lilly and Company Company Details
Table 62. Eli Lilly and Company Business Overview
Table 63. Eli Lilly and Company Cisplatin Product
Table 64. Eli Lilly and Company Revenue in Cisplatin Business (2016-2021) & (US$ Million)
Table 65. Eli Lilly and Company Recent Development
Table 66. Hospira Company Details
Table 67. Hospira Business Overview
Table 68. Hospira Cisplatin Product
Table 69. Hospira Revenue in Cisplatin Business (2016-2021) & (US$ Million)
Table 70. Hospira Recent Development
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Cisplatin Product
Table 74. Pfizer Revenue in Cisplatin Business (2016-2021) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Bedford Pharmaceuticals Company Details
Table 77. Bedford Pharmaceuticals Business Overview
Table 78. Bedford Pharmaceuticals Cisplatin Product
Table 79. Bedford Pharmaceuticals Revenue in Cisplatin Business (2016-2021) & (US$ Million)
Table 80. Bedford Pharmaceuticals Recent Development
Table 81. Alvogen Company Details
Table 82. Alvogen Business Overview
Table 83. Alvogen Cisplatin Product
Table 84. Alvogen Revenue in Cisplatin Business (2016-2021) & (US$ Million)
Table 85. Alvogen Recent Development
Table 86. Athenex Pharmaceutical Company Details
Table 87. Athenex Pharmaceutical Business Overview
Table 88. Athenex Pharmaceutical Cisplatin Product
Table 89. Athenex Pharmaceutical Revenue in Cisplatin Business (2016-2021) & (US$ Million)
Table 90. Athenex Pharmaceutical Recent Development
Table 91. Gland Pharma (Fosun Pharma) Company Details
Table 92. Gland Pharma (Fosun Pharma) Business Overview
Table 93. Gland Pharma (Fosun Pharma) Cisplatin Product
Table 94. Gland Pharma (Fosun Pharma) Revenue in Cisplatin Business (2016-2021) & (US$ Million)
Table 95. Gland Pharma (Fosun Pharma) Recent Development
Table 96. West-Ward Pharmaceuticals Company Details
Table 97. West-Ward Pharmaceuticals Business Overview
Table 98. West-Ward Pharmaceuticals Revenue in Cisplatin Business (2016-2021) & (US$ Million)
Table 99. West-Ward Pharmaceuticals Recent Development
Table 100. WG Critical Care Company Details
Table 101. WG Critical Care Business Overview
Table 102. WG Critical Care Cisplatin Product
Table 103. WG Critical Care Revenue in Cisplatin Business (2016-2021) & (US$ Million)
Table 104. WG Critical Care Recent Development
Table 105. David Bull Laboratories Company Details
Table 106. David Bull Laboratories Business Overview
Table 107. David Bull Laboratories Cisplatin Product
Table 108. David Bull Laboratories Revenue in Cisplatin Business (2016-2021) & (US$ Million)
Table 109. David Bull Laboratories Recent Development
Table 110. Omega Laboratories Company Details
Table 111. Omega Laboratories Business Overview
Table 112. Omega Laboratories Cisplatin Product
Table 113. Omega Laboratories Revenue in Cisplatin Business (2016-2021) & (US$ Million)
Table 114. Omega Laboratories Recent Development
Table 115. Fresenius Kabi Company Details
Table 116. Fresenius Kabi Business Overview
Table 117. Fresenius Kabi Cisplatin Product
Table 118. Fresenius Kabi Revenue in Cisplatin Business (2016-2021) & (US$ Million)
Table 119. Fresenius Kabi Recent Development
Table 120. TEVA Company Details
Table 121. TEVA Business Overview
Table 122. TEVA Cisplatin Product
Table 123. TEVA Revenue in Cisplatin Business (2016-2021) & (US$ Million)
Table 124. TEVA Recent Development
Table 125. Mylan Pharmaceuticals Company Details
Table 126. Mylan Pharmaceuticals Business Overview
Table 127. Mylan Pharmaceuticals Cisplatin Product
Table 128. Mylan Pharmaceuticals Revenue in Cisplatin Business (2016-2021) & (US$ Million)
Table 129. Mylan Pharmaceuticals Recent Development
Table 130. Yunnan Plant Pharmaceutical Company Details
Table 131. Yunnan Plant Pharmaceutical Business Overview
Table 132. Yunnan Plant Pharmaceutical Cisplatin Product
Table 133. Yunnan Plant Pharmaceutical Revenue in Cisplatin Business (2016-2021) & (US$ Million)
Table 134. Yunnan Plant Pharmaceutical Recent Development
Table 135. Yunnan Biological Valley Pharmaceutical Company Details
Table 136. Yunnan Biological Valley Pharmaceutical Business Overview
Table 137. Yunnan Biological Valley Pharmaceutical Cisplatin Product
Table 138. Yunnan Biological Valley Pharmaceutical Revenue in Cisplatin Business (2016-2021) & (US$ Million)
Table 139. Yunnan Biological Valley Pharmaceutical Recent Development
Table 140. Dezhou de Pharmaceutical Company Details
Table 141. Dezhou de Pharmaceutical Business Overview
Table 142. Dezhou de Pharmaceutical Cisplatin Product
Table 143. Dezhou de Pharmaceutical Revenue in Cisplatin Business (2016-2021) & (US$ Million)
Table 144. Dezhou de Pharmaceutical Recent Development
Table 145. Jiangsu Haosen Pharmaceutical Group Company Details
Table 146. Jiangsu Haosen Pharmaceutical Group Business Overview
Table 147. Jiangsu Haosen Pharmaceutical Group Cisplatin Product
Table 148. Jiangsu Haosen Pharmaceutical Group Revenue in Cisplatin Business (2016-2021) & (US$ Million)
Table 149. Jiangsu Haosen Pharmaceutical Group Recent Development
Table 150. Qilu Pharmaceutical Company Details
Table 151. Qilu Pharmaceutical Business Overview
Table 152. Qilu Pharmaceutical Cisplatin Product
Table 153. Qilu Pharmaceutical Revenue in Cisplatin Business (2016-2021) & (US$ Million)
Table 154. Qilu Pharmaceutical Recent Development
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cisplatin Market Share by Type: 2020 VS 2027
Figure 2. Tablets Features
Figure 3. Injection Features
Figure 4. Global Cisplatin Market Share by Application: 2020 VS 2027
Figure 5. Testicular Cancer Case Studies
Figure 6. Osteosarcoma Case Studies
Figure 7. Breast Cancer Case Studies
Figure 8. Cisplatin Report Years Considered
Figure 9. Global Cisplatin Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Cisplatin Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Cisplatin Market Share by Regions: 2020 VS 2027
Figure 12. Global Cisplatin Market Share by Regions (2022-2027)
Figure 13. Global Cisplatin Market Share by Players in 2020
Figure 14. Global Top Cisplatin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cisplatin as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Cisplatin Revenue in 2020
Figure 16. Global Cisplatin Revenue Market Share by Type (2016-2021)
Figure 17. Global Cisplatin Revenue Market Share by Type (2022-2027)
Figure 18. North America Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Cisplatin Market Share by Type (2016-2027)
Figure 20. North America Cisplatin Market Share by Application (2016-2027)
Figure 21. North America Cisplatin Market Share by Country (2016-2027)
Figure 22. United States Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Cisplatin Market Share by Type (2016-2027)
Figure 26. Europe Cisplatin Market Share by Application (2016-2027)
Figure 27. Europe Cisplatin Market Share by Country (2016-2027)
Figure 28. Germany Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Cisplatin Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Cisplatin Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Cisplatin Market Share by Region (2016-2027)
Figure 38. China Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Cisplatin Market Share by Type (2016-2027)
Figure 46. Latin America Cisplatin Market Share by Application (2016-2027)
Figure 47. Latin America Cisplatin Market Share by Country (2016-2027)
Figure 48. Mexico Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Cisplatin Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Cisplatin Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Cisplatin Market Share by Country (2016-2027)
Figure 54. Turkey Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Cisplatin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Eli Lilly and Company Revenue Growth Rate in Cisplatin Business (2016-2021)
Figure 58. Hospira Revenue Growth Rate in Cisplatin Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in Cisplatin Business (2016-2021)
Figure 60. Bedford Pharmaceuticals Revenue Growth Rate in Cisplatin Business (2016-2021)
Figure 61. Alvogen Revenue Growth Rate in Cisplatin Business (2016-2021)
Figure 62. Athenex Pharmaceutical Revenue Growth Rate in Cisplatin Business (2016-2021)
Figure 63. Gland Pharma (Fosun Pharma) Revenue Growth Rate in Cisplatin Business (2016-2021)
Figure 64. West-Ward Pharmaceuticals Revenue Growth Rate in Cisplatin Business (2016-2021)
Figure 65. WG Critical Care Revenue Growth Rate in Cisplatin Business (2016-2021)
Figure 66. David Bull Laboratories Revenue Growth Rate in Cisplatin Business (2016-2021)
Figure 67. Omega Laboratories Revenue Growth Rate in Cisplatin Business (2016-2021)
Figure 68. Fresenius Kabi Revenue Growth Rate in Cisplatin Business (2016-2021)
Figure 69. TEVA Revenue Growth Rate in Cisplatin Business (2016-2021)
Figure 70. Mylan Pharmaceuticals Revenue Growth Rate in Cisplatin Business (2016-2021)
Figure 71. Yunnan Plant Pharmaceutical Revenue Growth Rate in Cisplatin Business (2016-2021)
Figure 72. Yunnan Biological Valley Pharmaceutical Revenue Growth Rate in Cisplatin Business (2016-2021)
Figure 73. Dezhou de Pharmaceutical Revenue Growth Rate in Cisplatin Business (2016-2021)
Figure 74. Jiangsu Haosen Pharmaceutical Group Revenue Growth Rate in Cisplatin Business (2016-2021)
Figure 75. Qilu Pharmaceutical Revenue Growth Rate in Cisplatin Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
世界のシスプラチン市場規模・現状・予測（2021年-2027年） Cisplatin is one of the most commonly used drugs in current combined chemotherapy. Its chemical name is cis-dichlorodiaminoplatin, which is an inorganic metal complex. After chlorine dissociation, it cross-connects with the DNA of cancer cells, thus damaging the function of DNA.It may form intracycl…- 世界の肛門がん治療薬市場規模・現状・予測（2021年-2027年） A cancer can be defined when the normal cells lose their ability to control, their growth or multiplication and thus invade the tissues and spread to the body parts. Anal cancer is often called as squamous cell carcinoma which arises from the cells around or in the anal opening or in rare cases it m…
- 世界の胆管がん市場規模・現状・予測（2021年-2027年） Bile duct cancer or cholangiocarcinoma is a form of cancer in which epithelial cells are mutated, i.e., they show epithelial differentiation in the bile duct. It is a type of rare neoplasm. Market Analysis and Insights: Global Bile Duct Cancer Market The global Bile Duct Cancer market size is projec…
- 世界の乳がん用画像市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Breast Cancer Imaging Market The global Breast Cancer Imaging market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report…
- 世界のトリプルネガティブ乳がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Triple-Negative Breast Cancer Treatment Market The global Triple-Negative Breast Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…